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Background: Given that hearing loss occurs in 1 to 3 of 1,000 live births and approximately 90 to 95 percent of
them are born into hearing families, it is of importance and necessity to get better understanding about the carrier
rate and mutation spectrum of genes associated with hearing impairment in the general population.
Methods: 7,263 unrelated women of childbearing age with normal hearing and without family history of hearing
loss were tested with allele-specific PCR-based universal array. Further genetic testing were provided to the spouses
of the screened carriers. For those couples at risk, multiple choices were provided, including prenatal diagnosis.
Results: Among the 7,263 normal hearing participants, 303 subjects carried pathogenic mutations included in the
screening chip, which made the carrier rate 4.17%. Of the 303 screened carriers, 282 harbored heterozygous
mutated genes associated with autosomal recessive hearing loss, and 95 spouses took further genetic tests. 8 out
of the 9 couples harbored deafness-causing mutations in the same gene received prenatal diagnosis.
Conclusions: Given that nearly 90 to 95 percent of deaf and hard-of-hearing babies are born into hearing families,
better understanding about the carrier rate and mutation spectrum of genes associated with hearing impairment in
the female population of childbearing age may be of importance in carrier screening and genetic counseling.
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In China, approximately 30,000 infants are born with
congenital hearing loss per 20 million live births every
year [1,2]. Moreover, a similar number are affected with
hearing impairment before adulthood. Children with
hearing loss may confront with a series of obstacles,
given that spoken language is the predominant medium
of interpersonal communication and social interaction
[3]. Adequate auditory stimulation and sufficient lan-
guage exposure in early childhood are critical in their
subsequent linguistic acquisition, cognitive development,
as well as in psychosocial functioning [3-6]. In recogni-
tion of the ever-increasing and tremendous burden of* Correspondence: zhangxiaozhuang55@126.com
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reproduction in any medium, provided the orhearing impairment globally, the World Health Assem-
bly (WHA) passed a resolution on the prevention and
control of major causes of hearing loss [3,7]. As esti-
mated, more than 50 percent of prelingual hearing loss
are attributable to genetic factors [8]. Given that ap-
proximately 90 to 95 percent of deaf and hard-of-hear-
ing babies are born into hearing families [9], better
understanding about the carrier rate and mutation
spectrum of genes associated with hearing loss in the
female population of childbearing age may be of vital
importance in carrier screening, genetic testing, as well
as in providing accurate counseling.
Despite a great number of mutations in many genes
may contribute to hearing loss, the patterns of high
frequency mutations in certain populations and their
population-wide distributions make it meaningful to
initially select hotspot mutations for carrier screening
[10,11]. A microarray developed by CapitalBio (CapitalBio,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tions in Chinese population, based on large-scale epidemio-
logical studies across 28 provinces and municipalities
[12-16], indicating that the majority (>80%) of hereditary
hearing loss in Chinese patients were related to those nine
hotspot mutations. However, the carrier rate and mutation
spectrum of deafness- associated genes in the general popu-
lation was still under the veil. The parallelism offered by
the microarray platform makes it suited for genotyping of
genetically heterogeneous condition of hearing loss [17-19],
especially in the carrier screening practice.Methods
Subjects and DNA samples
A total of 7,263 unrelated women of childbearing age
with normal hearing and without family history of
hearing loss were enrolled in the study under an institu-
tional review board-approved protocol of informed
consent at the Guangdong Women and Children
Hospital Institutional Review Board and Ethics Commit-
tee of Guangzhou Medical College, China. The study
cohort was recruited from women came for (pre-)preg-
nancy examination at the Clinic of Guangdong Women
and Children Hospital, China. The majority of the par-
ticipants were from Guangdong Province, and a small
portion of them were from Hunan, Guangxi and Jiangxi
Provinces. The study cohort was of a significant charac-
teristic of South China origins. A comprehensive history
and physical examination record for each participating
subjects was obtained, including clinical history, infaust
gravidity, infection, aminoglycoside antibiotics exposure,
as well as genetic factors related to the hearing loss.
Blood samples were obtained from all participants and
genomic DNA was isolated from the whole blood by
standard procedures using Fuji DNA Blood Minikit.Carrier screening
Allele-specific PCR-based universal array was applied to
screen mutation carriers of deafness-associated genes in
the study cohort [10]. The Detection Array Kit (Registra-
tion Certificate for Medical Device No. 0903084, by
Chinese State Food and Drug Administration) was
purchased from CapitalBio Corporation (Beijing, China).
According to the manufacturer’ protocol, asymmetric
PCR was used to obtain sufficient single-strand DNA for
hybridization. After heat denaturation procedure, the
hybridization mixture was applied to the array. The slide
was incubated at 50°C for 1 hour, and washed twice at
42°C in 0.3% SSC/0.1% SDS and in 0.06% SSC. Finally,
the chip was imaged with a LuxScan™ 10 K-B Microarray
Scanner (CapitalBio, Beijing, China). The statistical ana-
lysis was performed using SPSS 17.0 (SPSS Inc.,
Chicago, USA).Genetic counseling and prenatal diagnosis
For the mutation carriers of genes associated with hear-
ing loss, elaborate genetic counseling were provided,
concerning the nature of the disease, the implications of
being carriers and the reproductive choices [20,21].
Further genetic testing, both allele-specific PCR-based
universal array detection and DNA sequence analysis,
were provided to the spouses of screened carriers.
As for those couples at risk and may need prenatal
diagnosis, detailed information was offered, regarding to
the fetal DNA sampling procedure, the risk of fetal mor-
tality, the chance of misdiagnosis, and the mortality and
morbidity of an abortion in case of affected fetus [22].
Fetal DNA for analysis can be obtained from either
chorionic villi, amniotic fluid, or fetal blood.Results
The carrier rate and mutation spectrum of deafness-
associated genes
Among the 7,263 normal hearing participants enrolled
in this study, 303 subjects carried pathogenic mutations
included in the screening chip, which made the carrier
rate 4.17% in the population under investigate. As shown
in Table 1, a total of 164 participating subjects carried
one type of the four common deafness-causing muta-
tions in GJB2 gene in the heterozygous state, and the
carrier rate was 2.26% in the population. Frame-shift c.
235 del C was the most prevalent mutation in the
Chinese hearing population with a carrier rate of 1.76%.
Followed by c. 299_300 del AT variation, the carrier rate
of which was 0.38%. Frame-shift c. 176_191 del 16 bp
accounted for 0.10% in group. Pathogenic mutation c. 35
del G accounted for 0.01% in the population under
study. Moreover, 109 subjects were found carrying
one type of the two confirmed pathogenic mutations
in SLC26A4 gene in the heterozygous state, which
accounted for 1.50% in the Chinese hearing population
under study. Aberrant splice-site alteration c. 919–2 A >
G accounted for 1.24% in the group, and the carrier rate
of c. 2168 A > G mutation was 0.26%. Furthermore, 9
subjects were found carrying pathogenic mutation c. 538
C > T in GJB3 gene in the heterozygous state, which
accounted for 0.12% in the Chinese hearing population
under investigate. In addition, 21 participants were
detected to be homoplasmy mutation carriers of mito-
chondrial DNA 12S rRNA gene, accounting for 0.29% of
the group. The carrier rate of m. 1555 A > G was 0.25%
in the population under investigate, and m. 1494 C > T
variation accounted for 0.04% of the group. Since
mitochondrial DNA 12S rRNA gene mutations was
important mechanism of genetic susceptibility to
aminoglycoside ototoxicity, screened carriers were
provided with detailed medication guide.
Table 1 The Carrier rate and mutation spectrum of deafness-associated genes in 7,263 hearing subjects
Gene Nucleotide change Carrier number Carrier rate (%)
GJB2 gene c. 35 del G 1 0.01%
c. 176_191 del 16 bp 7 0.10%
c. 235 del C 128 1.76%
c. 299_300 del AT 28 0.38%
GJB3 gene c. 538 C > T 9 0.12%
SLC26A4 gene c. 2168 A > G 19 0.26%
c. 919–2 A > G 90 1.24%
mtDNA 12S rRNA gene m. 1494 C > T 3 0.04%
m. 1555 A > G 18 0.25%
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Of the 303 screened carriers, 282 were found out to be
carrying heterozygous mutated genes associated with
autosomal recessive hearing loss. After the genetic coun-
seling, with regard to the nature of the disease, the im-
plications of being carriers and the reproductive choices,
were provided to the carriers and their families, 95
spouses were willing to take further genetic tests, includ-
ing the allele-specific PCR-based universal array to
detect high frequency deafness-associated mutations in
Chinese population, and DNA sequencing to analyze the
mutated gene of the wife. As shown in Additional file 1:
Table S1, nine couples harbored deafness-causing muta-
tions in the same gene.
Prenatal diagnosis and pregnancy outcomes
In the present study, eight out of the nine couples har-
bored deafness-causing mutations in the same gene
received prenatal diagnosis (Table 2). The pregnancy out-
comes were in accordance with the prenatal diagnosisTable 2 Prenatal diagnosis and pregnancy outcomes of coupl
gene
Family Mutated
gene
Genotype of the wife Genotype of the h
F1 GJB2 Heterozygous c. 299_300 del
AT
Heterozygous c. 235
F2 GJB2 Heterozygous c. 235 del C Heterozygous c. 235
F3 GJB2 Heterozygous c. 299_300 del
AT
Heterozygous c. 235
F4 GJB2 Heterozygous c. 235 del C Heterozygous c. 235
F5 GJB2 Heterozygous c. 235 del C Heterozygous c. 299
AT
F6 SLC26A4 Heterozygous c. 919–2 A > G Heterozygous c.154
F7 GJB2 Heterozygous c. 235 del C Heterozygous c. 512
AACG
F8 GJB2 Heterozygous c. 235 del C Heterozygous c. 109
F9 GJB2 Heterozygous c. 235 del C Heterozygous c. 109results. Five fetuses were mutation carriers and one har-
bored neither of the deafness-causing mutations of the par-
ents, performed normal hearing after births. One fetus
carried double deafness-causing mutations and developed
server hearing loss after birth. Detail information and early
intervention programs were provided to his parents. The
other couple with the fetus harbored double deafness-
causing mutations chose to terminate the affected preg-
nancy. Another couple carrying heterozygous mutated
genes associated with autosomal recessive hearing loss de-
cided not to have prenatal diagnosis. Their baby was born
with moderate hearing loss, and was provided with support
services and early intervention programs.
Discussion
In the present study, a cohort of 7,263 unrelated women
of childbearing age were investigated for the carrier rate
of genes associated with hearing loss in the South China
hearing female population. In the study cohort, 303
subjects carried pathogenic mutations associated withes harbored deafness-causing mutations in the same
usband Genotype of the fetus Pregnancy outcome
del C Heterozygous c. 235 del C Normal hearing
del C Homozygous c. 235 del C Severe hearing loss
del C Heterozygous c. 299_300 del AT Normal hearing
del C Homozygous c. 235 del C Termination of
pregnancy
_300 del Wild type Normal hearing
8 ins C Heterozygous c. 919–2 A > G Normal hearing
ins Heterozygous c. 235 del C Normal hearing
G > A Heterozygous c. 109 G > A Normal hearing
G > A Not know (refuse prenatal
diagnosis)
Moderate hearing loss
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population. Based on a comparatively large study popu-
lation, the figure could be reliable and representative,
and could be of importance in carrier screening and
genetic counseling of hearing loss, the most common
birth defect and the most prevalent sensorineural dis-
order in China.
Besides of the carrier rate, the mutation spectrum of
genes associated with hearing loss in South China hear-
ing population was also a core concern in the present
study. As previous reports suggested, variants of GJB2
gene could account for the molecular etiology of 8 to 72
percents of non-syndromic hearing impairment. In the
study cohort, GJB2 gene mutations accounted for
54.12% of the mutant alleles. The most common muta-
tion in Caucasians, c. 35 del G, accounted for only 0.33%
of mutant alleles in the South China hearing population.
Instead, c. 235 del C accounted for 42.24% of mutant al-
leles in the study population. c. 235 del C was also at the
highest rate in the Asian deaf populations [23]. More-
over, two pathogenic mutations c. 919–2 A > G and c.
2168 A > G in SLC26A4 gene were detected in 35.97%
of mutant alleles in the study cohort, with c. 919–2 A >
G being the most prevalent mutant form in SLC26A4
gene. The deafness-associated variation c. 538 C > T in
GJB3 gene was considered not common in the study
cohort. In addition, important causes of aminoglycoside-
induced and non-syndromic hearing loss, mitochondrial
DNA 12S rRNA gene m. 1555 A > G and m. 1494 C > T
variations accounted for 6.93% of mutant alleles in the
South China hearing population. The carrier rate of
mtDNA 12S rRNA gene mutations in the study cohort
was higher than that in the previous reports based on
populations from other parts of China, which may be
explained in phylogenetic insights [24,25].
The patterns of high frequency mutations in popula-
tions and their population-wide distributions made it
meaningful to initially select hotspot mutations for car-
rier screening. Yet the genetic heterogeneity of hearing
loss has proved a challenge for genetic testing using con-
ventional methods. Fortunately, the parallelism offered
by the microarray platform makes it ideally suited for
genotyping of genetically heterogeneous conditions such
as hearing loss. The allele-specific PCR-based universal
array allowed the parallel analysis of nine common varia-
tions in GJB2, GJB3, SLC26A4, and mitochondrial DNA
12S rRNA genes, and could easily be expanded or modi-
fied, according to further epidemiologic survey on the
carrier rate and mutation spectrum of genes associated
with hearing loss under certain ethnic background.
Conclusion
Previous researches mainly focused on molecular eti-
ology of hearing loss, which provided valuable data ofdeafness-causing mutations and their prevalences. How-
ever, without the implementation of carrier screening
and intervention programs, the average age at diagnosis
was 1.5 to 3 years, which was well beyond the beginning
of the critical interval for speech and language acquisi-
tion [26]. Diagnostic delay has a profound impact on
communicative competence, as well as cognitive and
psychosocial development. Considering the fact that
hearing loss occurs in 1 to 3 of 1,000 live births annually
and approximately 90 to 95 percent of them are born
into hearing families, it is of importance and vital neces-
sity to get better understanding about the carrier rate
and mutation spectrum of genes associated with hearing
impairment in the general population. It would be the
first step for constructing a national database, and would
then provides valuable information to health planners
and policy makers in planning programs and better
allocating resources. Moreover, since aminoglycoside
ototoxicity was a common health problem in China and
mitochondrial DNA 12S rRNA gene mutations were
supposed to be important causes of aminoglycoside-
induced hearing loss, screening of mutation carriers at
risk for ototoxicity and providing them with proper
medication guide would help decrease the incidence of
aminoglycoside-induced hearing loss.
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